RxDoctor Payments Data

Kayla Belfiori, PA

Physician Assistant · Mount Clemens, MINPI 1760077184

Payments from drug & device makers

$1,768in general payments, 2019–2025

Across 55 payments — averaging $32.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$480
  • Globus Medical$343
  • Boston Scientific$188
  • E.r. Squibb & Sons, L.L.C.$117
  • Bristol Myers Squibb$114
  • Pfizer$107
  • plus $419 from 10 others

What the payments were for

  • Food & beverage$1,768100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,768 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$5,609
Medicare patients
35
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine21$205,376
AubagioTeriflunomide14$132,060
Kesimpta PenOfatumumab13$113,948
BriviactBrivaracetam66$106,146
CopaxoneGlatiramer Acetate13$74,300
Nurtec OdtRimegepant Sulfate54$72,763
OxycontinOxycodone Hcl137$57,422
Emgality PenGalcanezumab-Gnlm54$38,153
UbrelvyUbrogepant21$22,087
Aimovig AutoinjectorErenumab-Aooe24$17,323
Xtampza ErOxycodone Myristate32$16,354
ZipsorDiclofenac Potassium13$15,050
Diclofenac Sodium67$13,051
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl52$11,408
Hysingla ErHydrocodone Bitartrate17$10,213

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt, Dilantin$107$77,11267 claims
AbbVieUbrelvy$94$22,08721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Mount Clemens

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →